Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.
Chris Kelly
Advertisement
Articles by Chris Kelly
Advertisement
Latest Updated Articles
A Roadmap to Phase I Challenges for Cell and Gene Therapy ProductsPublished: October 10th 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
3
ACT Brief: FDA Approval of Oral Wegovy, 2025’s Most-Read ACT Coverage, and Data Quality as the Foundation for AI
4
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
5